| AlloStim (bioengineered allogeneic immune cells) / Immunovative |
NCT02380443: AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer |
|
|
| Completed | 2a | 12 | US | AlloStim, CryoVax, Cryoablation | Immunovative Therapies, Ltd. | Colorectal Cancer Metastatic | 03/18 | 09/18 | | |
| Recruiting | 2 | 24 | US | AlloStim, StimVax | Mirror Biologics, Inc., Mirror Biologics, Inc. | Metastatic Colorectal Cancer | 11/24 | 04/25 | | |
| Not yet recruiting | 2 | 50 | US | AlloStim, Bavencio, Avelumab | Mirror Biologics, Inc. | Metastatic Colorectal Cancer | 06/25 | 11/25 | | |
NCT00861107: In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation |
|
|
| Completed | 1/2 | 50 | US | AlloStim-7, Priming Phase, percutaneous tumor cryoablation, In-Situ Vaccine Phase, AlloStim8 or AlloStim-9, Immune activation phase | Immunovative Therapies, Ltd. | Metastatic Cancer | 03/11 | 05/11 | | |
NCT00861965: Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers |
|
|
| Terminated | 1/2 | 2 | US | AlloStim-8 | Immunovative Therapies, Ltd. | Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma | 03/11 | 04/11 | | |
NCT00558675: A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy |
|
|
| Completed | 1/2 | 6 | RoW | AlloStim | Immunovative Therapies, Ltd., Hadassah Medical Organization | Hematological Malignancy, Leukemia, Lymphoma, Multiple Myeloma | 12/12 | 03/13 | | |
NCT01065441: Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer |
|
|
| Completed | 1/2 | 9 | RoW | AlloStim, Cryoablation | Michael Har-Noy, Hadassah Medical Organization | Solid Tumors Stage II, Stage III and Stage IV, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Sarcoma, Non-small Cell Lung Cancer | 12/12 | 07/13 | | |
NCT02018419: Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients |
|
|
| Withdrawn | 1/2 | 0 | US | AlloStim, InSituVax, Personalized anti-tumor vaccine, Cryoablation | Immunovative Therapies, Ltd. | Metastatic Breast Cancer | 03/14 | 03/14 | | |
NCT01923233: In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer |
|
|
| Withdrawn | 1/2 | 0 | RoW | AlloStim, InSituVax | Immunovative Therapies, Ltd. | Hepatocellular Carcinoma | 06/15 | 06/15 | | |
| Completed | 1/2 | 40 | US | AlloStim | Immunovative Therapies, Ltd., Mirror Biologics, Inc. | Virus Diseases, Pneumonia, COVID-19 Respiratory Infection, RSV Pneumonia, Influenza, Human, ARDS, Human | 03/23 | 04/23 | | |
